 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || UHE-103 / Therapeutics Inc
Trial completion, Trial completion date, Trial primary completion date: Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis (clinicaltrials.gov) - Apr 10, 2024
P1, N=42, Completed, Sponsor: Therapeutics, Inc.
Recruiting --> Completed | Trial completion date: Nov 2022 --> Nov 2023 | Trial primary completion date: Nov 2022 --> Nov 2023
- || UHE-103 / Therapeutics Inc
New P1 trial: Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis (clinicaltrials.gov) - May 4, 2022
P1, N=40, Recruiting, Sponsor: Therapeutics, Inc.
- |||| UHE-103 / Therapeutics Inc
Trial completion: A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis (clinicaltrials.gov) - Oct 27, 2021
P2, N=240, Completed, Sponsor: Therapeutics, Inc.
Recruiting --> Completed | Trial completion date: Nov 2022 --> Nov 2023 | Trial primary completion date: Nov 2022 --> Nov 2023 Active, not recruiting --> Completed
- | UHE-103 / Therapeutics Inc
Enrollment closed: A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis (clinicaltrials.gov) - Sep 11, 2019
P2, N=240, Active, not recruiting, Sponsor: Therapeutics, Inc.
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- |||| UHE-103 / Therapeutics Inc
New P2 trial: A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis (clinicaltrials.gov) - Mar 31, 2019
P2, N=200, Recruiting, Sponsor: Therapeutics, Inc.